ReviewEuropean journal of neurology2026
Artificial Intelligence for Improving the Management of People With Epilepsy in Low-and-Middle Income Countries.
Review in European journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundAbout 80% of people with epilepsy live in low-and-middle-income countries (LMICs) where the treatment gap is high. Limited access to neurologists, diagnostic tools, and antiseizure medications, combined with persistent stigma, contribute to poor outcomes, including premature mortality. Artificial intelligence (AI) offers potential to address these gaps through scalable, low-cost solutions for diagnosis, investigation, management, and monitoring.
methodsThis review examines three recent and complementary AI applications in epilepsy care for LMICs: a smartphone-based diagnostic tool for convulsive epilepsy developed using population-based data from five sub-Saharan African countries; an automated EEG interpretation system based on a deep learning model (SCORE-AI) validated across multicenter datasets; and a wearable-based deep learning model for detecting generalized convulsive seizures using low-cost smartwatches.
resultsThe smartphone diagnostic tool achieved area under the curve (AUC) 0.92-0.95 with sensitivity 85.0%-97.5% for identifying epilepsy with convulsive seizures using eight binary clinical features. SCORE-AI demonstrated expert-level performance (AUC 0.89-0.96, accuracy 85%-92%) for automated EEG classification across multiple validation datasets. The wearable seizure detection algorithm achieved 96% sensitivity with approximately one false alarm per 8 days. All three solutions were designed for deployment on widely accessible platforms.
conclusionsAI-driven approaches demonstrate feasibility for addressing diagnostic and monitoring gaps in resource-limited settings. However, implementation faces substantial challenges including infrastructure constraints, limited digital literacy, ethical considerations, and sociocultural factors. Successful deployment requires validation with large locally relevant datasets, context-adapted solutions, task-sharing strategies, implementation research, appropriate regulatory frameworks/certification, and community engagement to reduce the global epilepsy care gap.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.